Take advantage of a 100% OFF coupon code for the 'Stem Cells & AI in Drug Discovery: iPSCs and Organoids 101' course, created by Dr. Amogh Gopinathan Nair, available on Udemy.
This course, updated on December 04, 2025 and it is expired on December 05, 2025.
This course provides 1 hour(s) of expert-led training in English , designed to boost your Science skills.
Highly rated at 4.3-star stars from 0 reviews, it has already helped 643 students.
This exclusive coupon is shared by Anonymous,
at the price
39.99 $
0 $
Don’t miss this opportunity to level up your skills!
You can find the discounted coupon code for this course at the end of this article
Are you curious about how the future of drug discovery is shifting toward patient-specific, human-relevant systems? This course introduces you to the cutting-edge intersection of iPSC technology, AI, and organoids that is redefining biomedical research.
You will learn how induced pluripotent stem cells, or iPSCs, are generated from adult somatic cells using Yamanaka factors, and how they can be differentiated into functional, organ-specific tissues. These lab-grown tissues, known as organoids, are already being used in clinical trials in a dish to predict drug responses with far greater accuracy than animal models.
We will also explore how artificial intelligence is revolutionizing safety assessment, drug screening, and personalized medicine. Key topics include the FDA Modernization Act 2.0, preclinical safety pipelines, biobanking, and case studies in cardiology, oncology, and neurodegenerative disease research.
This course is ideal for students, pre-med learners, biotech professionals, and anyone passionate about the future of translational science. No prior lab experience required — just curiosity and a drive to understand the future of precision medicine.
What you will learn:
iPSC generation, differentiation, and therapeutic applications
Organoid models and their role in preclinical testing
AI-driven approaches in drug development
Ethical, regulatory, and safety frameworks in next-gen therapeutics
Join us and become fluent in the science behind tomorrow's medicine.